Genetically engineered antibody-based molecules show enhanced HIV-fighting abilities

Capitalizing on a new insight into HIV’s strategy for evading antibodies — proteins produced by the immune system to identify and wipe out invading objects such as viruses — Caltech researchers have developed antibody-based molecules that are more than 100 times better than our bodies’ own defenses at binding to and neutralizing HIV, when tested in vitro. The work suggests a novel approach that could be used to engineer more effective HIV-fighting drugs. —> Read More Here


Leave a Reply

Your email address will not be published. Required fields are marked *